The Charles Bronfman Institute for Personalized Medicine


At the Institute for Personalized Medicine, we are charged with focusing the efforts of the Icahn School of Medicine at Mount Sinai in Precision Medicine and healthcare while providing resources, scientific vision, and research programs that evaluate and advance the most promising aspects of personalized medicine for the diverse communities served by the Mount Sinai Health System.

We are leading the radical movement toward diagnoses and classification of disease according to a patient’s molecular profile, accommodating differences at all possible levels of exposure (genome plus environment plus lifestyle) and at all stages of the process, from prevention to post-treatment follow-up. This type of personalized medicine drives our Institute's research. Learn more about our program

The research interests of the Translational Initiatives for Pharmacogenomics (TIP) program are two-fold. Primarily, we seek to develop and successfully implement best practices for the clinical adoption of pharmacogenomics and personalized medicine. In addition, we are actively engaged in multiple research activities that seek to enhance the evidence base needed for clinical translation of certain significant drug-gene interactions. We are also trying to bridge the knowledge gap that exists between researchers and clinical providers. Learn more about TIP

BioMe provides essential research infrastructure and genotype-phenotype datasets for multi-disciplinary, programmatic research grants. Our faculty lead active federal grants – all funded by the National Institutes of Health (NIH). Learn more about our NIH funded programs